Abstract
Despite being the most common epithelial tumor in the anterior mediastinum, thymomas are uncommon tumors, as mediastinal pathology is unusual in general. There is controversy in terms of classification, staging, and clinical outcomes. Most publications about thymomas comprise small series of cases in which the authors have proposed their own views about classification, staging, or clinical behavior. In more recent times, some issues around thymomas have been resolved, but nevertheless, it is important to highlight that the published literature is rather empiric at best with little detail and with a wide spectrum of disparity in terms of pathology. It is important to clarify that thymoma is not the benign counterpart of thymic carcinoma nor is thymic carcinoma the malignant form of thymoma. Both conditions, thymoma and thymic carcinoma, represent unique clinicopathological entities, which require proper delineation not only for diagnostic purposes but also for prognosis, treatment, and outcomes. The clinical outcome in patients with thymoma is closely linked to the pathological stage at the time of diagnosis. In tumors that are encapsulated or minimally invasive, it is possible that only surgical resection offers a good clinical outcome while in those patients with invasive disease other treatment options such as radiation therapy and/or chemotherapy become possible alternatives.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Engels EA, Pfeiffer RM. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer. 2003;105:546–51.
Siesling S, van der Zwan JM, Izarzugaza I, et al. Rare thoracic cancers, including peritoneum mesothelioma. Eur J Cancer. 2012;48:949–60.
Engels EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol. 2010;5:S260–5.
Stoll DB, Lublin F, Brodovsky H, et al. Association of subacute motor neuropathy with thymoma. Cancer. 1984;54:770–2.
Guillan RA, Zelman S, Smalley RL, Iglesias PA. Malignant thymoma associated with myasthenia gravis and evidence of extrathoracic metastases. Cancer. 1971;27:823–30.
Tandan R, Taylor R, DiCostanzo DP, et al. Metastasizing thymoma and myasthenia gravis. Cancer. 1990;65:1286–90.
Patten SF, Dijkstra JWE. Associations of pemphigus and autoimmune disease with malignancy or thymoma. Int J Dermatol. 1994;33:836–42.
Miura K, Sasaki C, Katsushima I, et al. Pituitary-adrenocortical studies in a patient with Cushing’s syndrome induced by thymoma. J Clin Endocr. 1967;27:631–7.
Korn D, Gelderman A, Cage G, et al. Immune deficiencies aplastic anemia and abnormalities of lymphoid tissue in thymoma. N Engl J Med. 1967;276(24):1333–9.
Anderson ET, Vye MV. Dysproteinemia of the myeloma type associated with a thymoma. Ann Int Med. 1967;66:141–9.
Gilbert EF, Harley JB, Anido V, et al. Thymoma, plasma cell myeloma, red cell aplasia and malabsorption syndrome. Am J Med. 1968;44:820–9.
Friedman HD, Inman DA, Hutchinson RE, Poiesz BJ. Concurrent invasive thymoma and T-cell lymphoblastic leukemia and lymphoma: a case report with necropsy findings and literature review of thymoma and associated hematologic neoplasm. Am J Clin Pathol. 1994;101:432–7.
Lishner M, Ravid M, Shapira J, et al. Deta-T-lymphocytosis in a patient with thymoma. Cancer. 1994;74:2924–9.
Skinnider LF, Alexander S, Horsman D. Concurrent thymoma and lymphoma: a report of two cases. Hum Pathol. 1982;13:163–6.
Tormoehlen LM, Pascuzzi RM. Thymoma, myasthenia gravis, and other paraneoplastic syndromes. Hematol Oncol Clin North Am. 2008;22:509–26.
Okuma Y, Hosomi Y, Watanabe K, et al. Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo metropolitan cancer center. BMC Cancer. 2014;14:349–57.
Weissferdt A, Kalhor N, Bishop J, et al. Tymoma: a clinicopathological correlation of 1470 cases. Hum Pathol. 2018;73:7–15.
Carter BW, Okumura M, Detterbeck FC, Marom EM. Approaching the patient with an anterior mediastinal mass: a guide for radiologists. J Thorac Oncol. 2014;9:S110–8.
Reid H, Marcus R. Thymoma with a report of 5 cases. Br J Surg. 1937;xxxvi(143):271–9.
Andrus W, Foot NC. J Thorac Surg. 1937;6:648.
Wilson FN, Pritchard JE. Malignant thymoma. Canad Med Assoc J. 1945;53:444–54.
Symmers D. Malignant tumors and tumor-like growths of the thymic region. Ann Surg. 1932;95:544–72.
Ewing J. Neoplastic diseases: a treatise of tumors. 4th ed. Philadelphia: BJS Society; 1940. p. 1160.
Hellwig CA. Malignant thymoma: clinical-pathological study of eight cases. Surg Gynec Obst. 1941;73:851–63.
Lowenhaupt E. Tumors of the thymus in relation to thymic epithelial anlage. Cancer. 1948;1:547–62.
Seybold WD, McDonald JR, Clagett OT, Good CA. Tumors of the thymus. J Thoracic Surg. 1950;20:195–214.
Effler DB, McCormack LJ. Thymic neoplasms. J Thoracic Surg. 1956;31:60–77.
Thomson AD, Thackray AC. The histology of tumours of the thymus. Brit J Cancer. 1957;11:348–57.
Lattes R, Jonas S. The pathological and clinical features in eighty cases of thymoma. Bull N Y Acad Med. 1957;33:145–7.
Andritsakis GD, Sommers SC. Criteria for thymic cancer and clinical correlations of thymic tumors. J Thoracic Surg. 1959;37:273–90.
Bernatz PE, Harrison EG, Clagett OT. Thymoma: a clinicopathologic study. J Thorac Cardiovasc Surg. 1961;42:424–44.
Fechner RE. Recurrence of noninvasive thymomas: report of four cases and review of the literature. Cancer. 1969;23:1423–9.
Bernatz PE, Khonsari S, Harrison EG, Taylor WF. Thymoma: factors influencing prognosis. Surg Clin North Am. 1973;53:885–92.
Salyer WR, Eggleston JC. Thymoma: a clinical and pathological study of 65 cases. Cancer. 1976;37:229–49.
LeGolvan D, Abell MR. Thymomas. Cancer. 1977;39:2142–57.
Bergh NP, Gatzinsky P, Larsson S, et al. Tumors of the thymus and thymic region: I. clinicopathological studies on thymomas. Ann Thorac Surg. 1978;25:91–8.
Wilkins EW, Castleman B. Thymoma: a continuing survey at the Massachusetts General Hospital. Ann Thorac Surg. 1979;28:252–6.
Jain U, Frable WJ. Thymoma: analysis of benign and malignant criteria. J Thorac Cardiovasc Surg. 1974;67:310–21.
Kirchner T, Schalke B, Buchwald J, et al. Well-differentiated carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol. 1992;16:1153–69.
Kirchner T, Muller-Hermelink HK. New approaches to the diagnosis of thymic epithelial tumors. Prog Surg Pathol. 1989;10:167–89.
Giraud F, Fabien N, Auger C, et al. Human epithelial thymic tumours: heterogeneity in immunostaining of epithelial cell markers and thymic hormones. Thymus. 1990;15:15–29.
Dawson A, Ibrahim NBN, Gibbs AR. Observer variation in the histopathological classification of thymoma: correlation with prognosis. J Clin Pathol. 1994;47:519–23.
Pescarmona E, Rendina EA, Venuta F, et al. The prognostic implications of thymoma histologic subtyping: a study of 80 consecutive cases. Am J Clin Pathol. 1990;93:190–5.
Ricci C, Rendina E, Pescarmona E, et al. Correlations between histological type, clinical behavior, and prognosis in thymoma. Thorax. 1989;44:455–60.
Ho FCS, Fu KH, Lam SY, et al. Evaluation of a histogenetic classification for thymic epithelial tumours. Histopathology. 1994;25:21–9.
Tan PH, Sng ITY. Thymoma—a study of 60 cases in Singapore. Histopathology. 1995;26:509–18.
Close PM, Kirchner T, Uys CJ, Muller-Hermelink HK. Reproducibility of a histogenetic classification of thymic epithelial tumours. Histopathology. 1995;26:339–43.
Kuo TT, Lo SK. Thymoma: a study of the pathologic classification of 71 cases with evaluation of the Muller-Hermelink system. Hum Pathol. 1993;24:766–71.
Quintanilla L, Wilkins EW, Ferry JA, Harris NL. Thymoma—morphologic subclassification correlates with invasiveness and immunohistologic features: a study of 122 cases. Hum Pathol. 1993;24:958–69.
Quintanilla L, Wilkins EW, Choi N, et al. Thymoma: histologic subclassification is an independent prognostic factor. Cancer. 1994;74:606–17.
Lewis JE, Wick MR, Scheithauer BW, et al. Thymoma: a clinicopathologic review. Cancer. 1987;60:2727–43.
World Health Organization International Histological Classification of Tumours. Histological typing of tumours of the thymus. Rosa J. in collaboration with L.H. Sobin and Pathologists in 8 countries. 2nd ed. Berlin: Springer-Verlag; 1999.
Moran CA, Suster S. On the histologic heterogeneity of thymic epithelial neoplasms. Am J Clin Pathol. 2000;114:760–6.
Suster S, Moran CA. Thymoma, atypical thymoma, and thymic carcinoma: a novel conceptual approach to the classification of thymic epithelial neoplasms. Am J Clin Pathol. 1999;111:826–33.
Rieker RJ, Hoegel J, Morresei-Hauf A, et al. Histologic classification of thymic epithelial tumors: comparison of established classifications schemes. Int J Cancer. 2002;98:900–6.
Moran CA, Weissferdt A, Kalhor N, et al. Thymoma I: a clinicopathologic correlation of 250 cases with emphasis on the World Health Organization schema. Am J Clin Pathol. 2012;137:444–50.
Guerra F, Rendina EA, Venuta F, et al. Does the world health organization histological classification predict outcomes after thymomectomy? Results of a multicenter study on 750 patients. Eur J Cardiothoracic Surgery. 2015;48:48–54.
Moran CA, Kalhor N, Suster S. Invasive spindle cell thymomas (WHO type a): a clinicopathologic correlation of 41 cases. Am J Clin Pathol. 2010;134:793–8.
Moran CA. Thymoma staging: a comparison of the different systems. Adv Anat Pathol. 2021;28(5):298–306.
Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48:2485–92.
Moran CA, Walsh G, Suster S, Kaiser L. Thymoma II: a clinicopoathologic correlation of 250 cases with a proposed staging system with emphasis on pathologic assessment. Am J Clin Pathol. 2012;137:451–61.
Weissferdt A, Moran CA. The histomorphologic spectrum of spindle cell thymoma. Hum Pathol. 2014;45:437–45.
Baran JL, Magro CM, King M, et al. Atypical thymoma: a report of seven patients. Ann Thorac Surg. 2004;78:411–6.
Nonaka D, Rosai J. Is there a spectrum of cytologic atypia in type a thymomas analogous to that seen in type B thymomas? A pilot study of 13 cases. Am J Surg Pathol. 2012;36(6):889–94.
Suster S, Rosai J. Cystic thymomas: a clinicopathologic study of ten cases. Cancer. 1992;69:92–7.
Moran CA, Koss MN. Rhabdomyomatous thymoma. Am J Surg Pathol. 1993;17:633–6.
Moran CA, Suster S, Koss MN. Plasma cell-rich thymoma. Am J Clin Pathol. 1994;102:199–201.
Suster S, Moran CA, Chan KC. Thymoma with pseudosarcomatous stroma: report of an unusual histologic variant of thymic epithelial neoplasm that may simulate carcinosarcoma. Am J Surg Pathol. 1997;21:1316–23.
Yoneda S, Marx A, Heimann S, et al. Low-grade metaplastic carcinoma of the thymus. Histopathology. 1999;35:19–30.
Yoneda S, Marx A, Muller-Hermelink HK. Low-grade metaplastic carcinomas of the thymus: biphasic thymic epithelial tumors with mesenchymal metaplasia—an update. Pathol Res Pract. 1999;195:555–63.
Suster S, Moran CA. Micronodular thymoma with lymphoid B-cell hyperplasia: clinicopathologic and immunohistochemical study of eighteen cases of a distinctive morphologic variant of thymic epithelial neoplasm. Am J Surg Pathol. 1999;23:955–62.
Moran CA, Suster S. Thymoma with prominent cystic and hemorrhagic changes and areas of necrosis and infarction: a clinicopathologic study of 25 cases. Am J Surg Pathol. 2001;25:1086–90.
Kuo T. Sclerosing thymoma—a possible phenomenon of regression. Histopathology. 1994;25:289–91.
Moran CA, Suster S. “Ancient” (sclerosing) thymoma: a clinicopathologic study of 10 cases. Am J Clin Pathol. 2004;121:867–71.
Weissferdt A, Kalhor N, Suster S, Moran CA. Adenomatoid spindle cell thymomas: a clinicopathological and immunohistochemical study of 20 cases. Am J Surg Pathol. 2010;34:15644–1549.
Kalhor N, Suster S, Moran CA. Spindle cell thymoma (WHO type a) with prominent papillary and pseudopapillary features: a clinicopathologic and immunohistochemical study of 10 cases. Am J Surg Pathol. 2011;35:372–7.
Adam P, Hakroush S, Hofman I, et al. Thymoma with loss of keratin expression (and giant cells): a potential diagnostic pitfall. Virch Arch. 2014;465:313–20.
Fukuda T, Ohnishi Y, Emura I, Tachikawa S. Microcystic variant of thymoma: histological and immunohistochemical findings in two cases. Virch Arch. 1992;420:185–9.
Weissferdt A, Moran CA. Desmoplastic spindle cell thymomas: a clinicopathologic and immunohistochemical study of 14 cases. Hum Pathol. 2013;44:623–7.
Weissferdt A, Moran CA. Thymomas with prominent glandular differentiation: a clinicopathologic and immunohistochemical study of 12 cases. Hum Pathol. 2013;44:1612–6.
Weissferdt A, Moran CA. Thymomas with extensive clear cell component: a clinicopathologic and immunohistochemical study of nine cases. Am J Clin Pathol. 2016;146:132–6.
Weissferdt A, Moran CA. Spindle cell thymomas with neuroendocrine morphology: a clinicopathological and immunohistochemical study of 18 cases. Histopathology. 2014;65:111–8.
Weissferdt A, Moran CA. Thymomas with prominent signet ring cell-like features: a clinicopathological and immunohistochemical study of 10 cases. Hum Pathol. 2012;43:1881–6.
Suster S, Moran CA. Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. Am J Surg Pathol. 1996;20:1469–80.
Weissferdt A, Kalhor N, Moran CA. Combined thymoma-thymic seminoma: report of two cases of a heretofore unreported association. Hum Pathol. 2014;45:2168–72.
Gamondes JP, Balawi A, Greenland T, et al. Seventeen years of surgical treatment of thymoma: factor influencing survival. Eur J Cardiothorac Surg. 1991;5:124–31.
Macchiarini P, Chella A, Ducci F, et al. Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer. 1991;68:706–13.
Fornaseiro A, Daniele O, Ghiotto C, et al. Chemotherapy of invasive thymoma. J Clin Oncol. 1990;8:1419–23.
Loehrer PJ, Kim KM, Aisner SC, et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. J Clin Oncol. 1994;12:1164–8.
Yokoi K, Matsuguma H, Nakahara R, et al. Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone. J Thorac Oncol. 2007;2:73–8.
Kim ES, Putnam JB, Komaki R, et al. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymoma: final report. Lung Cancer. 2004;44:369–79.
Kunitoh H, Tamura T, Shibata T, et al. A phase II trial of dose-dense chemotherapy, followed by surgical resection and/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan clinical oncology group trial (JCOG 9606). Br J Cancer. 2010;103:6–11.
Kondo K. Therapy for thymic epithelial tumors. Gen Thorac Cardiovasc Surg. 2014;62:468–74.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Strange, C.D. et al. (2023). Thymoma. In: Moran, C.A., Truong, M.T., de Groot, P.M. (eds) The Thorax. Springer, Cham. https://doi.org/10.1007/978-3-031-21040-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-031-21040-2_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-21039-6
Online ISBN: 978-3-031-21040-2
eBook Packages: MedicineMedicine (R0)